Physician

Annada Kumar Das, M.D.

According to 2025 Medicare claims, Annada Das, M.D. (NPI: 1275556862) practices general practice in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Kings, NY. This provider's primary affiliated billing organization is ANNADA K DAS M D P C (NPI: 1205350485) and primary practice location at 11235-8511. Das is affiliated with the HHC ACO Inc (ACO ID: A1675), participating under the MSSP model.

Das' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 423 traditional Medicare patients, billed 1,177 HCPCS/CPT codes, and received $105,842 in Medicare payments. The top billing code was 99285 (Emergency department visit with high level of medical decision making). Part D data shows 865 prescription claims across 94 beneficiaries totaling $57,708 in drug costs, led by Wixela Inhub (Fluticasone Propion/Salmeterol). DME data shows 17 claims. Open Payments data shows 2 records totaling $29. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $92,611 and ending at $105,842. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $53,662 to $57,708. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $347 and ending at $469.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	407	953	$92,611
2016	342	967	$77,377
2017	189	659	$62,016
2018	229	835	$84,415
2019	145	808	$71,692
2020	68	577	$46,743
2021	344	996	$111,734
2022	608	1,269	$146,866
2023	552	1,339	$144,720
2024	423	1,177	$105,842

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	123	793	$53,662
2016	117	685	$41,291
2017	64	580	$50,431
2018	58	634	$55,184
2019	51	689	$59,652
2020	52	812	$88,424
2021	99	924	$110,945
2022	113	962	$122,391
2023	138	1,017	$94,280
2024	94	865	$57,708

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	53	$873
2016	12	39	$611
2017	N/R	43	$418
2018	N/R	28	$300
2019	14	52	$522
2020	11	44	$404
2021	12	51	$493
2022	14	38	$353
2023	11	23	$324
2024	N/R	17	$280

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99285	Emergency department visit with high level of medical decision making	171	172	$144
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	66	211	$107
99284	Emergency department visit with moderate level of medical decision making	114	115	$97
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	54	148	$75
94010	Test to measure expiratory airflow and volume	62	113	$23

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Wixela Inhub	Fluticasone Propion/Salmeterol	12	450	$2,584
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	480	$1,896
Rosuvastatin Calcium	Rosuvastatin Calcium	31	2,670	$829
Albuterol Sulfate Hfa	Albuterol Sulfate	41	1,800	$812
Omeprazole	Omeprazole	48	3,120	$501

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	17	$280

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$29	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Annada Kumar Das, M.D.?

Tedicare shows public-source Medicare data for Annada Kumar Das, M.D. (NPI 1275556862), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Annada Kumar Das, M.D. have ACO affiliation data?

Annada Kumar Das, M.D. is shown with ACO affiliation data for HHC ACO Inc (MSSP, ACO ID A1675).

What billing organization is linked to Annada Kumar Das, M.D.?

Annada Kumar Das, M.D. is linked to ANNADA K DAS M D P C (billing NPI 1205350485) in the available physician profile data.

Does Annada Kumar Das, M.D. have Open Payments data?

Annada Kumar Das, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.